Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6678467 | 0.86 | PNMT (0.37) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL6672325 | 0.84 | PNMT (0.38) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL6677716 | 0.84 | PNMT (0.35) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL6675606 | 0.84 | PNMT (0.35) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL61027 | 0.83 | PNMT (0.49) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL29843943 | 0.83 | PNMT (0.49) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL6676042 | 0.82 | PNMT (0.36) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL29138460 | 0.82 | PNMT (0.36) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL6675588 | 0.79 | PNMT (0.37) | PNMTNPC1RAB9ADRD2DRD4 | |
| SCHEMBL7052932 | 0.79 | PNMT (0.38) | PNMTNPC1RAB9ADRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-3902808-B1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3902810-B1 | CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3356374-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3902807-B1 | ORGANOMETALLIC CHAIN TRANSFER AGENTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-12275810-B2 | Telechelic polyolefins and processes for preparing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-12180314-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-31 | — | — | US | disclosed |
| US-12129368-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-10-29 | — | — | US | disclosed |
| EP-4435013-A2 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | Dow Global Technologies LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-0963990-A1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| WO-1999048605-A1 | ION EXCHANGED ALUMINIUM-MAGNESIUM OR FLUORINATED MAGNESIUM SILICATE AEROGELS AND CATALYST SUPPORTS THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999041289-A1 | IMPROVED OLEFIN POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1999006449-A1 | ZWITTERIONIC CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999006413-A1 | CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999006412-A1 | PERFLUORONAPHTHYL SUBSTITUTED BORON CONTAINING CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
| EP-0617044-B1 | Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound | MITSUI CHEMICALS INC (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-5360921-A | REACTING LITHIUM, SODIUM OR POTASSIUM SALT OF A CYCLOPENTADIENE DERIVATIVE WITH A SILICON OR GERMANIUM HALIDE COMPOUND IN THE PRESENCE OF A CYANIDE OR A THIOCYANATE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-01 | — | — | US | disclosed |
| EP-0617044-A2 | Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129368-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | PNMT 3858/4885NPC1 1682/4885RAB9A 4806/4885 |
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | CCT2, TCP1, ECH1 | PNMT 1496/4885NPC1 3703/4885RAB9A 4811/4885 |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | PNMT 3858/4885NPC1 1682/4885RAB9A 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.